Research Article
Safety Assessment of Ubiquinol Acetate: Subchronic Toxicity and Genotoxicity Studies
Table 7
Effect of ubiquinol acetate on hematological parameters in male rats.
| Parameters | Units | Group & Dose (mg/kg b.w.) | G1, | G2, | G3, | G4, | G1R, | G4R, | 0 | 150 | 300 | 600 | 0 | 600 |
| Total WBC count | 103/μl | 6.50 ± 0.99 | 6.79 ± 0.86 | 6.76± 1.03 | 6.63 ± 1.38 | 6.00±1.18 | 7.25±1.72 |
| Total RBC count | 106/μl | 9.04 ± 0.51 | 9.11 ± 0.34 | 8.83± 0.41 | 8.64± 0.33 | 8.60±0.70 | 8.61±0.6 |
| Hemoglobin | g/dL | 15.62±0.48 | 15.58±0.38 | 15.64±0.46 | 14.85±0.61 | 15.90±0.93 | 15.42±0.76 |
| Hematocrit | % | 48.22±1.97 | 48.48±1.74 | 48.46±1.78 | 45.67±2.11 | 46.34±3.56 | 45.2±2.93 |
| MCV | fL | 53.39±1.92 | 53.28±2.94 | 54.94±1.52 | 52.92±3.01 | 53.90±1.91 | 52.54±1.83 |
| MCH | pg | 17.28±0.72 | 17.12±0.84 | 17.72±0.61 | 17.22±1.00 | 18.54±0.7 | 17.94±0.63 |
| MCHC | g/dL | 32.39±0.67 | 32.15±0.59 | 32.28±0.62 | 32.54±0.64 | 34.40±0.58 | 34.16±0.64 |
| Neutrophils | 103/μl | 1.02±0.26 | 1.35±0.49 | 1.41±0.51 | 1.32±0.72 | 0.98±0.36 | 1.07±0.27 |
| Lymphocytes | 103/μl | 5.07±0.88 | 5.01±0.75 | 4.95±0.56 | 4.91±1.04 | 4.64±0.92 | 5.78±1.40 |
| Monocytes | 103/μl | 0.21±0.08 | 0.18±0.05 | 0.18±0.06 | 0.17±0.07 | 0.18±0.06 | 0.22±0.12 |
| Eosinophils | 103/μl | 0.11±0.04 | 0.13±0.04 | 0.11±0.05 | 0.11±0.04 | 0.15±0.04 | 0.13±0.05 |
| Basophils | 103/μl | 0.01±0.00 | 0.01±0.01 | 0.01±0.00 | 0.01±0.00 | 0.01±0.01 | 0.01±0.00 |
| LUC | 103/μl | 0.09±0.03 | 0.11±0.04 | 0.09±0.05 | 0.11±0.05 | 0.03±0.03 | 0.05±0.03 |
| Platelet count | 103/μl | 777.0±83.43 | 637.30±146.39 | 688.90±185.00 | 845.80±105.67 | 732.20±154.39 | 931.40±123.82 |
| Blood clotting time | Seconds | 154.20±11.64 | 165.10±23.39 | 165.80±23.72 | 154.90±27.74 | 169.00±28.52 | 164.60±27.41 |
|
|
Mean ± SD for 10 rats/sex/group (G1, G2, G3, G4) and 5 rats/sex/group (G1R, G4R); : statistically significant compared to the control group (p < 0.05). |